From: The effect of HIV-1 Vif polymorphisms on A3G anti-viral activity in an in vivo mouse model
FMLV-2A | NL43 | W11R | K22E | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
KO | A3GLow | A3GHigh | KO | A3GLow | A3GHigh | KO | A3GLow | A3GHigh | KO | A3GLow | A3GHigh | |
#G to A | 7 | 27 | 116 | 1 | 2 | 12 | 1 | 1 | 18 | 5 | 57 | 63 |
#other | 37 | 19 | 43 | 67 | 28 | 71 | 13 | 6 | 12 | 26 | 34 | 49 |
#mice | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 4 | 3 | 3 | 3 | 3 |
#clones | 42 | 40 | 41 | 42 | 41 | 53 | 49 | 42 | 45 | 50 | 45 | 48 |
#bp | 24,612 | 23,440 | 24,026 | 24,612 | 24,026 | 31,058 | 28,714 | 22,268 | 26,370 | 29,300 | 26,370 | 28,128 |
G to A freq. ×10−3 | 0.28 | 1.15 | 4.83 | 0.04 | 0.08 | 0.39 | 0.03 | 0.04 | 0.68 | 0.17 | 2.16 | 2.24 |
Other freq. ×10−3 | 1.50 | 0.81 | 1.79 | 2.72 | 1.17 | 2.29 | 0.45 | 0.27 | 0.46 | 0.89 | 1.29 | 1.74 |
#stop codons | 2 | 4 | 46 | 0 | 1 | 4 | 0 | 0 | 7 | 0 | 15 | 31 |
K22H | Y40H | G143R | |||||||
---|---|---|---|---|---|---|---|---|---|
KO | A3GLow | A3GHigh | KO | A3GLow | A3GHigh | KO | A3GLow | A3GHigh | |
#G to A | 3 | 29 | 62 | 0 | 10 | 27 | 2 | 7 | 9 |
#other | 22 | 28 | 49 | 18 | 21 | 5 | 11 | 13 | 10 |
#mice | 3 | 3 | 3 | 3 | 4 | 3 | 4 | 3 | 3 |
#clones | 44 | 45 | 46 | 45 | 52 | 41 | 41 | 41 | 39 |
#bp | 25,784 | 26,370 | 26,956 | 26,370 | 30,472 | 24,026 | 24,026 | 24,026 | 22,854 |
G to A freq. ×10−3 | 0.16 | 1.10 | 2.30 | 0.00 | 0.33 | 1.12 | 0.08 | 0.29 | 0.39 |
Other freq. ×10−3 | 0.85 | 1.06 | 1.82 | 0.68 | 0.69 | 0.21 | 0.46 | 0.54 | 0.44 |
#stop codons | 0 | 14 | 25 | 0 | 0 | 7 | 1 | 1 | 1 |